These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28028610)

  • 1. Incidence and clinical outcomes of intestinal Behçet's disease in Korea, 2011-2014: a nationwide population-based study.
    Han M; Jung YS; Kim WH; Cheon JH; Park S
    J Gastroenterol; 2017 Aug; 52(8):920-928. PubMed ID: 28028610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence and Clinical Outcomes of Inflammatory Bowel Disease in South Korea, 2011-2014: A Nationwide Population-Based Study.
    Jung YS; Han M; Kim WH; Park S; Cheon JH
    Dig Dis Sci; 2017 Aug; 62(8):2102-2112. PubMed ID: 28593437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of age at diagnosis and sex on clinical course and long-term prognosis of intestinal Behcet's disease.
    Jung YS; Yoon JY; Hong SP; Kim TI; Kim WH; Cheon JH
    Inflamm Bowel Dis; 2012 Jun; 18(6):1064-71. PubMed ID: 21793128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer Risk in Patients with Intestinal Behçet's Disease: A Nationwide Population-Based Study.
    Han M; Jung YS; Kim WH; Cheon JH; Park S
    Gut Liver; 2018 Jul; 12(4):433-439. PubMed ID: 29429154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence, prevalence, and mortality of Adamantiades-Behçet's disease in Korea: a nationwide, population-based study (2006-2015).
    Lee YB; Lee SY; Choi JY; Lee JH; Chae HS; Kim JW; Han KD; Park YG; Yu DS
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):999-1003. PubMed ID: 28940547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significant Decline in the Incidence of Behçet's Disease in South Korea: A Nationwide Population-Based Study (2004-2017).
    Jun JB; Kim HJ; Kazmi SZ; Kang T; Kim KB; Kang MJ; Ahn HS
    Arthritis Care Res (Hoboken); 2021 Nov; 73(11):1689-1696. PubMed ID: 32770715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimal Treatment Approaches to Intestinal Behçet's Disease Complicated by Myelodysplastic Syndrome: The KASID and KSBD Multicenter Study.
    Park JB; Han SJ; Lee SB; Kim DH; Cheon JH; Hwang SW; Ye BD; Yang SK; Park SJ; Park SH;
    Yonsei Med J; 2024 May; 65(5):265-275. PubMed ID: 38653565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors and Outcomes of Emergency Room Visits in Intestinal Behçet's Disease.
    Park J; Cheon JH; Park Y; Park SJ; Kim TI; Kim WH
    Digestion; 2017 Nov; 96(4):231-238. PubMed ID: 29131059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes of intestinal Behçet's disease: A 30-year cohort study at a tertiary hospital in South Korea.
    Park J; Park SJ; Park JJ; Kim TI; Cheon JH
    J Gastroenterol Hepatol; 2023 Mar; 38(3):386-392. PubMed ID: 36346041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors and outcomes of acute lower gastrointestinal bleeding in intestinal Behçet's disease.
    Park J; Cheon JH; Park YE; Lee YJ; Lee HJ; Park SJ; Hong SP; Kim TI; Kim WH
    Int J Colorectal Dis; 2017 May; 32(5):745-751. PubMed ID: 27924367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-Saccharomyces cerevisiae antibody in intestinal Behçet's disease patients: relation to clinical course.
    Choi CH; Kim TI; Kim BC; Shin SJ; Lee SK; Kim WH; Kim HS
    Dis Colon Rectum; 2006 Dec; 49(12):1849-59. PubMed ID: 17080284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated treatment strategies for intestinal Behçet's disease.
    Park YE; Cheon JH
    Korean J Intern Med; 2018 Jan; 33(1):1-19. PubMed ID: 29207867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and risk factors for gallstone and renal stone formation in patients with intestinal Behçet's disease.
    Song J; Park SJ; Park JJ; Kim TI; Park J; Cheon JH
    Korean J Intern Med; 2024 Sep; 39(5):770-782. PubMed ID: 39135522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of Behçet's disease in Korea: data from Health Insurance Review and Assessment Service from 2011 to 2015.
    Kim JN; Kwak SG; Choe JY; Kim SK
    Clin Exp Rheumatol; 2017; 35 Suppl 108(6):38-42. PubMed ID: 28134076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome predictors for intestinal Behçet's disease.
    Park JJ; Kim WH; Cheon JH
    Yonsei Med J; 2013 Sep; 54(5):1084-90. PubMed ID: 23918555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Outcomes and Predictors of Sustained Response in Patients with Intestinal Behcet's Disease Treated with Infliximab.
    Zou J; Ji DN; Cai JF; Guan JL; Bao ZJ
    Dig Dis Sci; 2017 Feb; 62(2):441-447. PubMed ID: 28044230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of age at diagnosis on long-term prognosis in patients with intestinal Behçet's disease.
    Chang JY; Park SJ; Park JJ; Kim TI; Cheon JH; Park J
    J Gastroenterol Hepatol; 2024 Mar; 39(3):519-526. PubMed ID: 38149352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden.
    Everhov ÅH; Halfvarson J; Myrelid P; Sachs MC; Nordenvall C; Söderling J; Ekbom A; Neovius M; Ludvigsson JF; Askling J; Olén O
    Gastroenterology; 2018 Feb; 154(3):518-528.e15. PubMed ID: 29102619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term clinical outcomes of Crohn's disease and intestinal Behcet's disease.
    Jung YS; Cheon JH; Park SJ; Hong SP; Kim TI; Kim WH
    Inflamm Bowel Dis; 2013 Jan; 19(1):99-105. PubMed ID: 22508364
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between smoking and Behçet's disease: a nationwide population-based study in Korea.
    Lee YB; Lee JH; Lee SY; Lee JH; Yu DS; Han KD; Park YG
    J Eur Acad Dermatol Venereol; 2019 Nov; 33(11):2114-2122. PubMed ID: 31121063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.